Components
• Proper use of TM/CAM by providers. Increase capacity of TM/CAM providers to make proper use of TM/CAM products and therapies.
• Proper use of TM/CAM by consumers. Increase capacity of consumers to make informed decisions about use of TM/CAM products and therapies.
"... we must broaden the knowledge base of CAM and conventional health care practitioners to encompass the full repertoire of safe and effective health care practices - truly expanding the horizons of health care. These practices can then be integrated into optimal interdisciplinary treatment plans developed in cooperation with patients. These imperatives dictate serious efforts in research, training, education and communication..."45
WHO strategy
WHO will encourage countries to organize training programmes for allopathic practitioners to enable them to acquire basic knowledge of TM/CAM and to promote licensed practice of therapies.
WHO will continue to develop authoritative references for Member States, such as the WHO Monographs on Selected Medicinal Plants. It will also develop information and education materials (including translations) and a TM/CAM web-site to raise awareness of the need for rational use of TM/CAM, and to guide the public in their safe use.
Critical indicators
Strategy objective |
Number of WHO Member States with national research institutel for TM/CAM/Total number of WHO Member States |
1999 status |
2005 target |
WHO Member States with national research institute for TM/CAM |
19/191 |
10% |
18% |
l A national research institute is here defined as a government-supported national research institute.
Expected outcomes for 2002 - 2005
• Basic training in commonly used TM/CAM therapies for allopathic practitioners.
• Basic training in primary health care for TM practitioners.
• Reliable information for consumers on proper use of TM/CAM therapies.
• Improved communication between allopathic practitioners and their patients concerning use of TM/CAM.